Skip to content

Effects of Terminal Visual Feedback Therapy After Immersive Virtual Reality in Patients With Chronic Shoulder Pain

Unknown statusNot applicableNCT05640661
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this clinical trial is effect of terminal visual feedback therapy following the use of immersive virtual reality(VRi) effects on pain,kinesiophobia, fear of pain, disability, self-efficacy, grip strength and range of motion in motion in people with chronic shoulder pain compare with just VRi. The main question\[s\] it aims to answer are: * Can terminal visual feedback therapy following the use of immersive virtual reality software decrease movement-evoked pain in patients with chronic shoulder pain compared with just VRi? * Can terminal visual feedback therapy following the use of immersive virtual reality software increase shoulder flexion range of motion in patients with chronic shoulder pain compared with just VRi? Participants will use a visual feedback therapy following the use of immersive virtual reality software compared with just specific VRi software

Study details

Official title
Effects of Terminal Visual Feedback Therapy After Immersive Virtual Reality in Patients With Chronic Shoulder Pain : Mixed-Methods Randomized Clinical Trial
Conditions
Interventions
  • Device: Oculus Quest II
  • Device: Oculus Quest II
Sponsor
University of Malaga
Start date
2023-12-04
Primary completion
2024-07-03
Sex
All
Age range
from 18 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
Spain
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * People from 18 to 65 years old * Shoulder pain of at least three months of evolution located in the proximal anterolateral region of the shoulder * Presenting shoulder pain during movements with a history of traumatic or insidious onset * Agree to participate in the study and sign the informed consent Exclusion Criteria: * Shoulder pain resulting from a dysfunction of the cervical spine. * Cognitive deficits * Uso of medicines for pain control in the previous 24 hours, * A history of neurological or psychiatric disorders * Adhesive capsulitis syndrome (limited passive range of motion of the shoulder: external rotation \< 30°; elevation \< 150°) * Patients with shoulder instability * Previous surgery of the shoulder * Rheumatic diseases

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05640661